Diagnostic Paracentesis in Treatment-Naïve Suspected Ovarian Cancer with Ascites
In a treatment-naïve patient with suspected ovarian cancer and ascites, diagnostic paracentesis should generally NOT be performed, as it has limited diagnostic value (only 67% sensitivity even in confirmed cancer) and carries risk of tumor dissemination; instead, proceed directly to contrast-enhanced CT imaging for staging and surgical planning. 1, 2
Rationale Against Routine Paracentesis
Limited Diagnostic Yield
- Even in women with confirmed epithelial ovarian cancer and ascites, cytology is positive for malignancy in only 67.1% of cases, meaning one-third of patients with known cancer will have false-negative ascitic fluid cytology 1
- This poor sensitivity makes paracentesis unreliable for establishing or excluding the diagnosis of ovarian cancer 1
Risk of Tumor Dissemination
- Paracentesis carries the potential risk of spreading cancer cells along the needle tract, which is particularly concerning in treatment-naïve patients where the goal is optimal primary cytoreduction 1
- The procedure may cause serious harm, including bowel perforation (which can be fatal), ascitic leaks, and other complications in 32-36% of patients 3
Superior Alternative Diagnostic Pathway
- Contrast-enhanced CT abdomen/pelvis is the most useful preoperative evaluation tool, with reported staging accuracy up to 94% 2
- CT provides comprehensive assessment of locoregregional tumor extent, peritoneal disease, omental involvement, mesenteric implants, liver metastases, and lymphadenopathy 2
- CT chest with IV contrast should be added to detect pulmonary metastases and assess for pleural disease, which impacts surgical planning 2
When Paracentesis May Be Considered
Diagnostic Uncertainty Scenarios
- If there is genuine uncertainty about whether ascites is malignant versus cirrhotic in origin, paracentesis with serum-ascites albumin gradient (SAAG) calculation can differentiate: SAAG ≥11 g/L suggests portal hypertension (cirrhosis), while SAAG <11 g/L suggests peritoneal carcinomatosis 4, 5
- When preoperative histologic confirmation is needed and the ovarian mass itself is not accessible for biopsy, paracentesis may provide cytologic diagnosis in approximately two-thirds of cases 1
Symptomatic Relief (Not Diagnostic)
- Paracentesis is primarily indicated for symptomatic management of tense ascites causing abdominal distension, pain, or respiratory compromise—not for diagnosis 6, 3
- When performed for symptom relief, 81% of patients experience improvement in symptoms (particularly abdominal distension, pain, and nausea) within 24 hours 3
Recommended Diagnostic Algorithm
Initial imaging: Obtain contrast-enhanced CT abdomen/pelvis and CT chest with IV contrast for comprehensive staging 2
Assess resectability: Use CT findings to determine likelihood of optimal primary cytoreduction versus need for neoadjuvant chemotherapy 2
Skip paracentesis unless:
Proceed to surgical staging: Surgical exploration remains the reference standard for ovarian cancer diagnosis and staging 2
Common Pitfalls to Avoid
- Do not delay definitive imaging by performing paracentesis first—CT provides far more comprehensive staging information 2
- Do not rely on negative cytology to exclude ovarian cancer, given the 33% false-negative rate even in confirmed cases 1
- Do not perform ultrasound-guided paracentesis routinely for suspected ovarian cancer unless there is diagnostic uncertainty about the etiology of ascites 6, 7
- If paracentesis is performed for symptom relief, drain up to 5 liters without clamping, leave the drain for no more than 6 hours, and avoid routine IV fluid replacement unless specifically indicated 6